Search

Your search keyword '"Poulter NR"' showing total 547 results

Search Constraints

Start Over You searched for: Author "Poulter NR" Remove constraint Author: "Poulter NR"
547 results on '"Poulter NR"'

Search Results

1. Global blood pressure screening during the COVID-19 pandemic: results from the May Measurement Month 2021 campaign

2. Renin-Angiotensin System Inhibitors in Patients With COVID-19: A Meta-Analysis of Randomized Controlled Trials Led by the International Society of Hypertension

3. May Measurement Month 2019: an analysis of blood pressure screening results from Cameroon

4. May Measurement Month 2019: an analysis of blood pressure screening results from Brazil

5. May Measurement Month 2018: an analysis of blood pressure screening results from Mexico

6. Long‐term efficacy and safety of combined insulin and glucagon‐like peptide‐1 therapy: Evidence from the LEADER trial

7. Effects of Liraglutide Versus Placebo on Cardiovascular Events in Patients With Type 2 Diabetes Mellitus and Chronic Kidney Disease

8. May Measurement Month 2019: an analysis of blood pressure screening results from Tunisia

9. Risk factors for kidney disorders in patients with type 2 diabetes at high cardiovascular risk: An exploratory analysis (DEVOTE 12)

10. May Measurement Month 2019: an analysis of blood pressure screening results from India (vol 23, pg B73, 2021)

11. Development of a hypoglycaemia risk score to identify high-risk individuals with advanced type 2 diabetes in DEVOTE

12. Risk of severe hypoglycaemia and its impact in type 2 diabetes in DEVOTE

13. Glomerular Filtration Rate and Associated Risks of Cardiovascular Events, Mortality, and Severe Hypoglycemia in Patients with Type 2 Diabetes: Secondary Analysis (DEVOTE 11)

14. May Measurement Month 2017: screening for hypertension in Nigeria—Sub-Saharan Africa

15. MMM17-Cameroon, analysis and opportunities—Sub-Saharan Africa

26. May measurement month 2018: a pragmatic global screening campaign to raise awareness of blood pressure by the International Society of Hypertension (vol 40, pg 2006, 2019)

27. May Measurement Month 2017 : an analysis of blood pressure screening results from United Kingdom and Republic of Ireland - Europe

28. May Measurement Month 2017 in Russia: hypertension treatment and control-Europe

29. May Measurement Month 2017: analysis of the blood pressure screening results in Argentina-Americas

30. Lower rates of cardiovascular events and mortality associated with liraglutide use in patients treated with basal insulin: A DEVOTE subanalysis (DEVOTE 10)

31. May measurement month 2017: an analysis of the blood pressure screening campaign results in Indonesia-South-East Asia and Australasia

32. May Measurement Month 2017: an analysis of blood pressure screening results in South Africa-Sub-Saharan Africa

33. Publisher Correction: Genetic analysis of over 1 million people identifies 535 new loci associated with blood pressure traits (vol 50, pg 1412, 2018)

36. Liraglutide and Renal Outcomes in Type 2 Diabetes

38. Effects of liraglutide on cardiovascular outcomes in patients with type 2 diabetes mellitus with or without history of myocardial infarction or stroke

39. Effect of Liraglutide on Cardiovascular Events in Patients With Type 2 Diabetes Mellitus and Polyvascular Disease: Results of the LEADER Trial

43. Investigating the stratified efficacy and safety of pharmacological blood pressure-lowering: an overall protocol for individual patient-level data meta-analyses of over 300 000 randomised participants in the new phase of the Blood Pressure Lowering Treatment Trialists' Collaboration (BPLTTC)

46. LEADER-4: blood pressure control in patients with type 2 diabetes and high cardiovascular risk: baseline data from the LEADER randomized trial

49. Liraglutid und renale Endpunkte bei Typ 2 Diabetes: Ergebnisse der LEADER Studie

50. HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: Evidence from genetic analysis and randomised trials

Catalog

Books, media, physical & digital resources